Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1744 dose-ranging study in asthma versus placebo and Foradil
2009-013395-48Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of olodaterol in asthma (6 arms), sponsored by Boehringer Ingelheim. Primary endpoint: FEV1 area under the curve from 0 to 24 hours at end of treatment period. Started Sep 2009; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-013395-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013395-48.